Genmab A/S - ADR (GMAB) Price & News - Google Finance

Get the latest Genmab A/S - ADR (GMAB) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

CouponFollow Extension

87%
OFF

Genmab A/S (GMAB) Stock Price, News, Quote & History - Yahoo …

1 week from now

KRYS Krystal Biotech, Inc. 195.87. -1.87%. Find the latest Genmab A/S (GMAB) stock quote, history, news and other vital information to help you with your stock trading and investing.

yahoo.com

$22.76
OFF

Genmab A-S Stock Price | GMAB Stock Quote, News, And History

1 week from now

3 days ago · Discover the best brokers for stock trading and ordering other assets! On Monday 11/04/2024 the closing price of the Genmab A-S (spons. ADRs) share was $22.76 on BTT. …

businessinsider.com

5%
OFF

Genmab A/S (GMAB) Stock Price, Quote & News - Stock Analysis

1 week from now

2 days ago · Media Release COPENHAGEN, Denmark; June 3, 2024 Results from innovaTV207 evaluating tisotumab vedotin, showing 32.5% confirmed objective response rate in patients …

stockanalysis.com

$29
OFF

What Is The Current Price Target And Forecast For Genmab (GMAB)

1 week from now

The current on short-term price targets is based on 9 reports. The forecasts for Genmab A/S Sponsored ADR (GMAB) range from a low of $29 to a high of $50. The average price target …

zacks.com

$45.20
OFF

Genmab A/S (GMAB) Stock Forecast And Price Target 2024

1 week from now

6 days ago · According to the 10 analysts' twelve-month price targets for Genmab A/S, the average price target is $45.20. The highest price target for GMAB is $50.00, while the lowest …

marketbeat.com

$503
OFF

Genmab A/S (GMAB) Stock Price, News & Analysis - MarketBeat

1 week from now

3 days ago · Genmab A/S (GMAB) raised $503 million in an initial public offering on Thursday, July 18th 2019. The company issued 27,800,000 shares at a price of $18.11 per share. BofA …

marketbeat.com

6%
OFF

GMAB News Today | Why Did Genmab A/S Stock Go Down Today?

1 week from now

Nov 7, 2024 · Envestnet Asset Management Inc. lowered its stake in shares of Genmab A/S (NASDAQ:GMAB - Free Report) by 2.6% during the 2nd quarter, according to the company in …

marketbeat.com

€217.80
OFF

GMAB Stock Price Quote - Morningstar

1 week from now

6 days ago · Price vs Fair Value. View History. GMAB is trading within a range we consider fairly valued. Price. €217.80. Nov 11, 2024. Fair Value. €290.40. Nov 11, 2024.

morningstar.com

77%
OFF

GMAB - Genmab A/S ADR Stock Price - Barchart.com

1 week from now

GMAB : 28.94 (+0.77%) INVA : 16.26 (+1.31%) 3 Biotech Stocks Bursting With Investment Potential stocknews.com - Fri Nov 24, 2023. The biotech industry is well-positioned for robust …

barchart.com

FAQs about Genmab A/S - ADR (GMAB) Price & News - Google Finance Coupon?

Should you buy Genmab A/S (GMB)?

Investors should be bearish about investing in Genmab A/S for these reasons: The stock has been trading down recently, showing a 1.0% decrease, which may raise concerns about short-term performance. Genmab A/S has a beta of 0.97, suggesting that the stock's price is closely correlated with market movements, potentially leading to higher volatility. ...

How did Genmab A/S's Stock perform in 2024?

Genmab A/S's stock was trading at $31.84 on January 1st, 2024. Since then, GMAB shares have decreased by 12.7% and is now trading at $27.80. View the best growth stocks for 2024 here. How were Genmab A/S's earnings last quarter? Genmab A/S (NASDAQ:GMAB) posted its quarterly earnings results on Thursday, August, 8th. ...

Is Genmab A good stock to buy?

Recent price target updates from analysts suggest a potential upside of 76.37% from the current stock price, providing a growth opportunity for investors. Institutional investors have been increasing their stakes in Genmab A/S, indicating confidence in the company's future prospects. ...

Is gmab a good stock to buy?

GMAB is trading within a range we consider fairly valued. Genmab AS is a Copenhagen-based biotechnology company specializing in antibody therapeutics for the treatment of cancer. Genmab’s proprietary antibody technologies are DuoBody, HexaBody, DuoHexaBody, and HexElect. ...

How many shares does gmab a/s (gmab) have?

Purchases Shares of 5,607 Genmab A/S (NASDAQ:GMAB) Sign up to receive the latest news and ratings for GMAB and its competitors with MarketBeat's FREE daily newsletter. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. ...

How many restricted stock units does Genmab have?

Company Announcement COPENHAGEN, Denmark; September 26, 2024 – Genmab A/S (Nasdaq: GMAB) announced today that the Board decided to grant 23,954 restricted stock units and 13,915 warrants to employees ... ...